Home Covid-19
The lung disease Covid-19, which is caused by the novel coronavirus known as SARS-CoV-2, has the world in its grip. GBN is bringing biobanks and researchers together to gain insights into the disease and develop treatments.
See here for information on handling biosamples as well as further literature.
From swabs to whole blood – these German biobanks are collecting SARS-CoV-2 samples.
04/05/2024
21 biobanks from six countries took part in the proficiency testing programme of the German Biobank Node (GBN) to check basic biobank processes.
03/20/2024
Das Laborjournal hat mit PD Dr. Sara Nußbeck und Dr. Cornelia Specht über die Zukunftsperspektive des German Biobank Node (GBN) gesprochen.
01/29/2024
Sara Nußbeck will take over the management of the German Biobank Node (GBN) together with Gabriele Anton and Michael Kiehntopf from 1 February 2024.
germanbiobanknode@charite.de
Tel. +49. 30. 450 536 347
Fax +49. 30. 450 753 69 38
© 2024 All rights reserved.